Miriam Quinlan

ORCID: 0009-0001-9612-7457
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Antifungal resistance and susceptibility
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Fungal Infections and Studies
  • Cardiac Arrest and Resuscitation
  • Chronic Lymphocytic Leukemia Research
  • Health and Medical Research Impacts
  • Organ Donation and Transplantation
  • Advances in Oncology and Radiotherapy
  • Peptidase Inhibition and Analysis
  • CNS Lymphoma Diagnosis and Treatment
  • IgG4-Related and Inflammatory Diseases
  • Neurological and metabolic disorders
  • Stroke Rehabilitation and Recovery
  • Actinomycetales infections and treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Neuroendocrine Tumor Research Advances
  • Neuroblastoma Research and Treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Innovations in Medical Education
  • Venous Thromboembolism Diagnosis and Management
  • Glioma Diagnosis and Treatment
  • Neurological Disorders and Treatments
  • Autopsy Techniques and Outcomes

Johns Hopkins University
2025

Johns Hopkins Medicine
2025

Case Western Reserve University
2025

Albany Medical Center Hospital
2024-2025

Kern Medical Center
2018

Saint Luke's Hospital
2015

The University of Kansas Health System
2015

UCLA Health
2015

Tufts Medical Center
2015

University of Missouri–Kansas City
2015

Patients with coccidioidal meningitis require lifelong antifungal therapy. Cumulative toxicity and lack of efficacy salvage therapy in the treatment some patients. In a retrospective review nine patients treated isavuconazole, successful was seen three stable disease confirmed six Isavuconazole may be useful addition to therapeutic choices currently available for meningitis.

10.1128/aac.02232-18 article EN Antimicrobial Agents and Chemotherapy 2018-12-17

National guidelines endorse recombinant tissue-type plasminogen activator (r-tPA) in eligible patients with acute ischemic stroke to improve patients' functional recovery. However, 23% 40% of ideal candidates for reperfusion are not treated, perhaps because the difficulty explaining benefits and risks r-tPA within frenetic pace emergency department care. To support better knowledge transfer creation a shared decision-making tool, we conducted qualitative interviews define information needs...

10.1161/circoutcomes.115.002003 article EN Circulation Cardiovascular Quality and Outcomes 2015-10-01

To report a case of and review the literature for mechanical thrombectomy-associated foreign body granuloma discuss benefit early recognition intervention.

10.1212/wnl.0000000000205392 article EN Neurology 2024-04-09

To report a case of anti-IgLON5 disease demonstrating cervical dystonia as part the clinical picture.

10.1212/wnl.0000000000205542 article EN Neurology 2024-04-09

Patients with coccidioidal meningitis require life-long antifungal therapy and cumulative toxicity from these agents may occur. Isavuconazole is the newest triazole has demonstrated a lower profile than voriconazole represent useful in meningitis, although no data regarding efficacy yet been presented. We conducted retrospective analysis of all patients treated at our centers. Data abstracted included demographic clinical information, results laboratory radiographic studies, serologic...

10.1093/ofid/ofy210.404 article EN cc-by-nc-nd Open Forum Infectious Diseases 2018-11-01
Coming Soon ...